Intas USFDA 483 cites Data Integrity, to
USFDA Inspection of Intas, Matoda, Sanand facility in India (FEI 3004011473); from 22 November 2022 to
Warning letters, 483s, Recalls, Import Alerts, Audit observations
USFDA Inspection of Intas, Matoda, Sanand facility in India (FEI 3004011473); from 22 November 2022 to
USFDA483 for Jubilant Roorkee cited deficient review of unexplained discrepancies, OOS (out of specifications),  deficient CAPAs. Jubilant Generics
USFDA 483 to Jubilant Roorkee cited inadequate review of unexplained discrepancies, aborting dissolution testing analysis for
USFDA 483 for Jubilant Roorke cited inadequacies in investigation of equipment breakdowns, error messages, alarms.
An USFDA 483 (2019) to Torrent cites deficient Process validation practices and procedures. The observations
Torrent Indrad, India (FEI 3005029956) was issued USFDA form 483 following inspections by USFDA inspectors Lata Mathew, Jogy
Following the USFDA inspection during 8-16 April 2019 at Torrent, Indrad, India (FEI 3005029956) by
USFDA 483 Torrent Indrad facility in India (FEI 3005029956); inspection from 8 April 2019 to
USFDA 483 to Lupin Pithampur unit cite Inadequacy of training and awareness across the management